Pharming Group N.V. ADR
(PHAR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Gross Profit | 290 | 1,010 | 580 | 680 | 940 |
| Operating Expenses | 0 | 370 | 680 | 820 | 1,230 |
| Operating Income | N/A | -370 | -680 | -820 | -1,230 |
| Pre-tax Income | 0 | -370 | -680 | -820 | -1,230 |
| Net Income Continuous | N/A | -370 | -680 | -820 | -1,230 |
| Net Income | $N/A | $-370 | $-680 | $-820 | $-1,230 |
| EBITDA(a) | $N/A | $320 | $-220 | $-340 | $-750 |